Ability Biotherapeutics Alternatives & Competitors
12 companies similar to Ability Biotherapeutics — Developing innovative targeted immuno therapeutics to addressing unmet medical n...
Companies similar to Ability Biotherapeutics
Anavo Therapeutics BV
UNLOCKING THE PHOSPHATASE TARGET CLASS
Leiden, The Netherlands
ImCheck Therapeutics
Bringing a novel class of Butyrophilin-targeted checkpoint modulators into the clinic
Marseille, France
ExeVir
Rapid Viral control in a world that needs it
Ghent, Belgium
Sensei Bio
We follow the immune system’s teachings to discover new treatments that inspire the body t...
Rockville, United States
Track all Ability Biotherapeutics competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Bright Peak Therapeutics
Better Biologics Through Chemistry
Basel, Switzerland
Volastra Therapeutics
Clinical stage biotech developing a powerful new class of cancer therapies exploiting chro...
New York, United States
DEM Biopharma, Inc.
Novel Target for Solid Tumors
Cambridge, United States
VitroScan
Predictive Testing Solutions
Leiden, The Netherlands
One Biosciences
Focused on generating precision medicines by leveraging the power of single-cell technol...
Paris, France
Treeline
Making medicines at the highest level
Watertown, United States
Crossbow Therapeutics, Inc
Established antibody engineering to target the untapped universe of intracellular cancer t...
Cambridge, United States
About Ability Biotherapeutics
Ability Biotherapeutics is an innovative company established in 2023 and headquartered in Canada. Operating within the Biotechnology and Life Sciences industries, the company's slogan captures its groundbreaking approach: "Developing innovative targeted immuno therapeutics to address unmet medical needs for cancer and...
Development of precision therapies, Immune cell modulating biotherapeutics, Antibody discovery and engineering, Product candidates pipeline
Biopharmaceutical companies, Research institutions, Healthcare providers, Patients with inflammatory diseases, Cancer patients
Targeted Immunotherapy, Cancer Treatment, Autoimmune Diseases, Biotherapeutics, Antibody Development, AI-Driven Drug Discovery, AbiLeap Discovery Engine, Multispecific Antibodies, Human IgG Antibodies, Immune Modulating Therapies, Antigen-Antibody Interactions, Logic-Gated Therapeutics, Cellular Microenvironment Response, AI/ML In Biotech, Biotech Innovation
B2B, Platform
Licensing, Performance Based, Product Sales
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Ability Biotherapeutics and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Ability Biotherapeutics on 15 Jun 2026. The 12 companies listed here were last checked between 12 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
